Saint Joseph Mercy Health System
Ann Arbor, Michigan, United States
Hospital department in Superior Township, Michigan
5301 McAuley Dr, Ypsilanti, MI 48197
About Saint Joseph Mercy Health System
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
NSABP Foundation Inc
2
Alliance Foundation Trials, LLC.
1
Mayo Clinic
1
Michigan State University
1
National Cancer Institute (NCI)
1
NovoCure GmbH
1
Vericel Corporation
1
Clinical Trials at Saint Joseph Mercy Health System
During the past decade, Saint Joseph Mercy Health System conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
2003-08-01
2007-07-01
Completed
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
2009-05-01
2018-02-01
Completed
1,613
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
2009-11-13
2017-12-31
Completed
2,204
An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI)
2012-02-01
2014-03-25
Completed
41
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
2016-12-01
2023-09-01
Active, not recruiting
276
Atezolizumab Immunotherapy in Patients With Advanced NSCLC
2017-11-01
2020-03-01
Unknown status
64
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saint Joseph Mercy Health System" #1 sponsor was "NSABP Foundation Inc" with 2 trials, followed by "Alliance Foundation Trials, LLC." with 1 trials
sponsored, "Mayo Clinic" with 1 trials sponsored, "Michigan State University" with 1 trials sponsored and "National Cancer Institute (NCI)"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Health System"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Saint Joseph Mercy Health System
According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Health System" are
"Breast Cancer" (2 trials), "Acute Stroke" (1 trials), "Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Saint Joseph Mercy Health System" in a lesser frequency.
Clinical Trials Intervention Types at Saint Joseph Mercy Health System
Most popular intervention types in "Saint Joseph Mercy Health System" are "Drug" (6 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "bevacizumab" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saint Joseph Mercy Health System
The vast majority of trials in "Saint Joseph Mercy Health System" are
6 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Saint Joseph Mercy Health System
Currently, there are NaN active trials in "Saint Joseph Mercy Health System".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Saint Joseph Mercy Health System,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Saint Joseph Mercy Health System, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".